Provenance du réseau au premier degré de Mehdi Paborji
Entité | Type d'entité | Industrie | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 11 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Mehdi Paborji via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
VERNALIS | Pharmaceuticals: Major | Chairman | |
DYAX CORP. | Pharmaceuticals: Major | Director/Board Member | |
RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Biotechnology | Chairman | |
CONSORT MEDICAL PLC | Pharmaceuticals: Major | Chairman | |
ACORDA THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder General Counsel Corporate Officer/Principal | |
Premier Research Group Ltd.
Premier Research Group Ltd. Miscellaneous Commercial ServicesCommercial Services Premier Research Group Ltd. provides contract research services to pharmaceutical industry. It engages in analgesics, neuroscience, medical devices, rare diseases and pediatrics. The company offers pediatric experience with both familiar and extremely rare childhood illnesses, including work at PICUs, NICUs, clinics, ERs and neonatal studies. Premier Research Group was founded in 2002 and is headquartered in Wokingham, the United Kingdom. | Miscellaneous Commercial Services | Chairman | |
The Medical Research Council
The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
QINETIQ GROUP PLC | Aerospace & Defense | Director/Board Member | |
Nodality, Inc.
Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin | |
Stanford University | College/University | Corporate Officer/Principal | |
UCB | Pharmaceuticals: Major | Director/Board Member | |
EVOTEC SE | Pharmaceuticals: Major | Director/Board Member | |
QinetiQ Ltd.
QinetiQ Ltd. Miscellaneous Commercial ServicesCommercial Services QinetiQ Ltd. provides technical, engineering, and research services for defense and security problems. It offers products and services for air, cyber, maritime, robotics, space, land, training, weapons, advisory systems, and target systems. The company was founded in June 2001 and is headquartered in Farnborough, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Ionix Pharmaceuticals Ltd.
Ionix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ionix Pharmaceuticals Ltd. used to develop analgesic medicines for the treatment of acute and chronic pain. Its drugs were used for the treatment of pain associated with chronic debilitating diseases such as osteoarthritis, diabetes, cancer and multiple sclerosis. The company was founded by Andrew Sandham, Phillip J. Birch, John Wood and Ann Gail Hayes in 2001 and was located in Cambridge, UK. | Pharmaceuticals: Major | Chairman | |
University of Cambridge | College/University | Doctorate Degree | |
OPTOS PLC | Medical Specialties | Chairman | |
Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
Wesleyan University | College/University | Undergraduate Degree | |
ABLYNX | Biotechnology | Chairman | |
Roche Holding (UK) Ltd.
Roche Holding (UK) Ltd. Pharmaceuticals: MajorHealth Technology Roche Holding (UK) Ltd. manufactures and sells drugs. It operates as a holding company for Roche Products Ltd. and Roche Diagnostics Ltd. Its pharmaceuticals include Copegus, a hepatitis C therapy, HIV inhibitor Fuzeon, and breast cancer therapy, Herceptin. The firm's consumer and professional tests include Accutrend glucose monitoring systems, CoaguChek blood coagulation tests, and the Amplicor line of DNA disease diagnostics. The company was founded in 1908 and is headquartered in Welwyn Garden City, UK. | Pharmaceuticals: Major | Chief Executive Officer | |
The University of Sheffield | College/University | Undergraduate Degree | |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
ATHERSYS, INC. | Biotechnology | Chairman | |
United States Senate | General Government | Corporate Officer/Principal | |
Domainex Ltd.
Domainex Ltd. Pharmaceuticals: MajorHealth Technology Domainex Ltd. operates as a drug discovery company. Its services include drug target expression, structural biology, virtual hit screening, medicinal chemistry, computational chemistry, assay development, and fragment based screening. The firm offers combinatorial domain hunting technology, and leadbuilder virtual hit screening software. The company was founded by Laurence Harris Pearl, Renos Savva, Paul Driscoll and Chrisostosmos Prodromou in 2001 and is headquartered in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
Ligand UK Development Ltd.
Ligand UK Development Ltd. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Ligand UK Development Ltd. is a company that manufactures pharmaceutical products. The company is based in Winnersh, UK. | Pharmaceuticals: Major | Director/Board Member | |
Kemianteollisuus ry | Director/Board Member | ||
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Biotechnology | Chief Executive Officer | |
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA. | Pharmaceuticals: Major | Director/Board Member | |
Laurantis Pharma Oy
Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Laurantis Pharma Oy engages in the development of pharmaceutical products. The company was founded in July 2008 and is headquartered in Turku, Finland. | Pharmaceuticals: Major | Director/Board Member | |
Harvard Law School | College/University | Graduate Degree | |
Columbia University College of Physicians & Surgeons | College/University | Doctorate Degree | |
HERANTIS PHARMA OYJ | Pharmaceuticals: Major | Chairman | |
MEREO BIOPHARMA GROUP PLC | Biotechnology | Chairman | |
Acorda Therapeutics Ltd.
Acorda Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Acorda Therapeutics Ltd. operates as a biopharmaceutical company. It manufactures pharmaceutical preparations and performs research and experimental development. The company was incorporated on March 03, 2009 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer President | |
SELLAS LIFE SCIENCES GROUP, INC. | Pharmaceuticals: Major | Chairman | |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
Biotie Therapies International Oy | Director/Board Member | ||
Sellas Life Sciences Group Ltd.
Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Chairman |
Statistiques
Internationale
Etats-Unis | 23 |
Royaume-Uni | 19 |
Finlande | 6 |
Belgique | 3 |
Allemagne | 2 |
Sectorielle
Health Technology | 33 |
Consumer Services | 9 |
Commercial Services | 6 |
Electronic Technology | 2 |
Government | 2 |
Opérationnelle
Director/Board Member | 78 |
Chairman | 39 |
Independent Dir/Board Member | 33 |
Corporate Officer/Principal | 26 |
Chief Executive Officer | 13 |
Relations les plus connectées
Insiders | |
---|---|
Mahendra Shah | 34 |
William Burns | 27 |
Peter John Fellner | 21 |
Don Bailey | 15 |
Jane Wasman | 14 |
Timo Ilari Veromaa | 12 |
Ronald Cohen | 11 |
David John Cook | 11 |
Andrew Hindman | 10 |
Stephen L. Bandak | 6 |
Kristian Rantala | 1 |
- Bourse
- Insiders
- Mehdi Paborji
- Connexions Sociétés